Veterinary Pharmacovigilance Market Size, Share & Trends Analysis Report By Solution (Software, Services), By Type (In-house, Contract Outsourcing), By Animal Type, By Product, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global veterinary pharmacovigilance market size was exhibited at USD 709.8 million in 2022 and is projected to hit around USD 2,520.45 million by 2032, growing at a CAGR of 13.51% during the forecast period 2023 to 2032.

Key Pointers:

  • One of the key trends in the veterinary pharmacovigilance market is the adoption of new technologies such as electronic reporting systems and data analytics tools. These technologies allow for more efficient and accurate monitoring of adverse events, and can help to identify potential safety issues before they become more serious.
  • By solution, software segment dominated the market in 2022, while services are expected to grow at the fastest CAGR of about 14.1%.
  • By product, anti-infectives held the largest share of over 46% of the market in 2022. Biologics segment on the other hand, is estimated to grow at the highest rate of over 14.2% over the next few years.
  • In-house segment held the dominant share of the market in 2022 in terms of type, while contract outsourcing is anticipated to grow at a notable rate of over 12%.
  • Dogs accounted for the largest share of the market in 2022 by animal type. Other animal types are projected to grow at the fastest rate of about 15% in the coming years.
  • North America dominated the market by region in 2022 with a share of about 42%. Asia Pacific region is estimated to grow at the fastest rate of over 15.2% from 2023 to 2032.
  • The veterinary pharmacovigilance market presents significant opportunities for companies that are able to innovate, differentiate themselves, and respond to the evolving needs of the animal health industry.

Veterinary Pharmacovigilance Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 805.69 million

Market Size by 2032

USD 2,520.45 million

Growth Rate From 2023 to 2032

CAGR of 13.51%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

Solution, Product, Type, Animal type

Market Analysis (Terms Used)

Value (US$ Million/Billion) or (Volume/Units)

Regional Scope

North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa

Key Companies Profiled

ArisGlobal; Accenture; Ennov; Sarjen Systems Pvt. Ltd.; Pharsafer Associates Limited; Knoell; Biologit; Indivirtus; Azierta Contract Science Support Consulting; Oy Medfiles Ltd.

 

The market is driven by several factors, including the increasing incidence of adverse drug reactions in animals, the rising adoption of companion animals, and the growing demand for animal-derived food products. Additionally, the increasing regulatory scrutiny and the need for stringent safety standards have led to the development of new pharmacovigilance technologies and tools. Accenture for instance, offers a range of Veterinary Vigilance services that include ICSR Case Processing , VeDDRA Coding, Signal Detection, Literature Management, EvVetMPD support, and Regulatory Intelligence. Growing industry requirements for aggregate reporting, expedited reporting, and management of signals are expected to propel the market growth in the coming years.

The COVID-19 pandemic has had both negative and positive impacts on the animal health market While it has created challenges, it has also created opportunities for companies to adapt and innovate, and has highlighted the importance of monitoring the safety and efficacy of animal health products in the context of global health crises. This supported the awareness and adoption of veterinary pharmacovigilance solutions. The field is an emerging sector within the animal healthcare market. It involves monitoring the safety and effectiveness of veterinary medicines, vaccines, and other animal health products, and reporting any adverse reactions or incidents that may occur. This information is then used to improve the safety and quality of these products and to protect animal health.With the growing concern for animal welfare and the increasing demand for animal-based food products, the market has gained significant attention in recent years.

Initiatives by key market participants is another factor fueling the market growth. In June 2018, Medfiles opened a new office in Japan to cater to European and Japanese clients with a range of services. These include pharmacovigilance, clinical trials, and analytical services, among others. In February 2022, Ennov, a key market player opened a new office in the U.S. in response to successful growth in the North American market. This expanded the company’s global footprint with a focus on building its pharmacovigilance capabilities. Ennov’s pharmacovigilance offerings include case intake, triage, signal detection and management for customers from human and veterinary life sciences market.

Some of the prominent players in the Veterinary Pharmacovigilance Market include:

  • ArisGlobal
  • Accenture
  • Ennov
  • Sarjen Systems Pvt. Ltd.
  • Pharsafer Associates Limited
  • Knoell
  • Biologit
  • Indivirtus
  • Azierta Contract Science Support Consulting
  • Oy Medfiles Ltd.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Veterinary Pharmacovigilance market.

By Solution 

  • Software
  • Services

By Product 

  • Biologics
  • Anti-infectives
  • Other Product

By Type 

  • In-house
  • Contract Outsourcing

By Animal Type 

  • Dogs
  • Cats
  • Other Animal Types

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global veterinary pharmacovigilance market size was exhibited at USD 709.8 million in 2022 and is projected to hit around USD 2,520.45 million by 2032

The global veterinary pharmacovigilance market is expected to grow at a compound annual growth rate of 13.51% from 2023 to 2032

Some key players operating in the veterinary pharmacovigilance market include ArisGlobal, Accenture, Ennov, Sarjen Systems Pvt. Ltd., Pharsafer Associates Limited, Knoell, Biologit, Indivirtus, Azierta Contract Science Support Consulting, and Oy Medfiles Ltd.

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased Database
                       1.3.2. Nova one advisor’s Internal Database
                       1.3.3. Secondary Sources & Third-Party Perspectives
                       1.3.4. Primary Research
                       1.3.5. Details of Primary Research
                   1.4. Information Analysis
                       1.4.1. Data Analysis Models
                   1.5. Market Formulation & Data Visualization
                   1.6. Data Validation & Publishing
                   1.7. Model Details
                   1.8. List of Secondary Sources
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
                   3.1. Market Lineage
                       3.1.1. Parent Market Analysis
                       3.1.2. Ancillary Market Analysis
                   3.2. Veterinary Pharmacovigilance Market - Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Increasing demand for Pharmacovigilance reporting
                           3.2.1.2. Increasing R&D activities and product launches
                           3.2.1.3. Supportive regulatory pharmacovigilance frameworks in key countries
                           3.2.1.4. Increasing pet population and humanization
                           3.2.1.5. Rising demand for animal-based products
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Under-reporting of Adverse Drug Events
                           3.2.2.2. Lack of Standard Regulations/ Regulatory Oversight in developing countries
                       3.2.3. Market Opportunity Analysis
                       3.2.4. Market Challenge Analysis
                   3.3. Business Environmental Tools Analysis: Veterinary Pharmacovigilance Market
                       3.3.1. Porter’s Five Forces Analysis
                       3.3.2. PESTLE Analysis
                   3.4. Regulatory Landscape
                   3.5. Covid-19 Impact Analysis
                   3.6. Estimated Animal Population, by key species & key countries, 2020 to 2022
Chapter 4. Veterinary Pharmacovigilance Market: Solution Estimates & Trend Analysis
                   4.1. Veterinary Pharmacovigilance Market, By Solution: Key Takeaways
                   4.2. Veterinary Pharmacovigilance Market: Solution Movement & Market Share Analysis, 2022 & 2032
                   4.3. Software
                       4.3.1. Global Software Market Estimates And Forecasts, 2020 - 2032
                   4.4. Services
                       4.4.1. Global Services Market Estimates And Forecasts, 2020 - 2032
Chapter 5. Veterinary Pharmacovigilance Market: Type Estimates & Trend Analysis
                   5.1. Veterinary Pharmacovigilance Market, By Type: Key Takeaways
                   5.2. Veterinary Pharmacovigilance Market: Type Movement & Market Share Analysis, 2022 & 2032
                   5.3. In-house
                       5.3.1. Global In-house Market Estimates And Forecasts, 2020 - 2032
                   5.4. Contract Outsourcing
                       5.4.1. Global Contract Outsourcing Market Estimates And Forecasts, 2020 - 2032
Chapter 6. Veterinary Pharmacovigilance Market: Product Estimates & Trend Analysis
                   6.1. Veterinary Pharmacovigilance Market, by Product: Key Takeaways
                   6.2. Veterinary Pharmacovigilance Market: Product Movement & Market Share Analysis, 2022 & 2032
                   6.3. Biologics
                       6.3.1. Global Biologics Market Estimates And Forecasts, 2020 - 2032
                   6.4. Anti-infectives
                       6.4.1. Global Anti-infectives Market Estimates And Forecasts, 2020 - 2032
                   6.5. Others
                       6.5.1. Global Other Products Market Estimates And Forecasts, 2020 - 2032
Chapter 7. Veterinary Pharmacovigilance Market: Animal Type Estimates & Trend Analysis
                   7.1. Veterinary Pharmacovigilance Market, By Animal Type: Key Takeaways
                   7.2. Veterinary Pharmacovigilance Market: Animal Type Movement & Market Share Analysis, 2022 & 2032
                   7.3. Dogs
                       7.3.1. Global Dogs Market Estimates And Forecasts, 2020 - 2032
                   7.4. Cats
                       7.4.1. Global Cats Market Estimates And Forecasts, 2020 - 2032
                   7.5. Other Animal Types
                       7.5.1. Global Other Animal Types Market Estimates And Forecasts, 2020 - 2032
Chapter 8. Veterinary Pharmacovigilance Market: Regional Estimates & Trend Analysis
                   8.1. Veterinary Pharmacovigilance Market: Regional Movement Analysis, 2022 & 2032
                   8.2. North America
                       8.2.1. North America Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.2.2. U.S.
                           8.2.2.1. Key Country Dynamics
                           8.2.2.2. U.S. Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.2.3. Canada
                           8.2.3.1. Key Country Dynamics
                           8.2.3.2. Canada Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                   8.3. Europe
                       8.3.1. Europe Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.3.2. U.K.
                           8.3.2.1. Key Country Dynamics
                           8.3.2.2. U.K. Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.3.3. Germany
                           8.3.3.1. Key Country Dynamics
                           8.3.3.2. Germany Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.3.4. France
                           8.3.4.1. Key Country Dynamics
                           8.3.4.2. France Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.3.5. Italy
                           8.3.5.1. Key Country Dynamics
                           8.3.5.2. Italy Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.3.6. Spain
                           8.3.6.1. Key Country Dynamics
                           8.3.6.2. Spain Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                   8.4. Asia Pacific
                       8.4.1. Asia Pacific Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.4.2. Japan
                           8.4.2.1. Key Country Dynamics
                           8.4.2.2. Japan Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.4.3. China
                           8.4.3.1. Key Country Dynamics
                           8.4.3.2. China Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.4.4. India
                           8.4.4.1. Key Country Dynamics
                           8.4.4.2. India Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.4.5. Australia
                           8.4.5.1. Key Country Dynamics
                           8.4.5.2. Australia Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.4.6. South Korea
                           8.4.6.1. Key Country Dynamics
                           8.4.6.2. South Korea Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                   8.5. Latin America
                       8.5.1. Latin America Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.5.2. Brazil
                           8.5.2.1. Key Country Dynamics
                           8.5.2.2. Brazil Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032 x`
                   8.6. Middle East & Africa
                       8.6.1. Middle East & Africa Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.6.2. South Africa
                           8.6.2.1. Key Country Dynamics
                           8.6.2.2. South Africa Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
                       8.6.3. Saudi Arabia
                           8.6.3.1. Key Country Dynamics
                           8.6.3.2. Saudi Arabia Veterinary Pharmacovigilance Market Estimates And Forecasts, 2020 - 2032
Chapter 9. Competitive Landscape
                   9.1. Company Categorization
                   9.2. Key Company Profiles
                       9.2.1. Company Overview
                       9.2.2. Financial Performance
                       9.2.3. Product/ Service Benchmarking
                       9.2.4. Strategy Mapping
                           9.2.4.1 ArisGlobal
                           9.2.4.2 Accenture
                           9.2.4.3 Ennov
                           9.2.4.4 Sarjen Systems Pvt. Ltd.
                           9.2.4.5 Pharsafer Associates Limited
                           9.2.4.6 Knoell
                           9.2.4.7 Biologit
                           9.2.4.8 Indivirtus
                           9.2.4.9 Azierta Contract Science Support Consulting
                           9.2.4.10 Oy Medfiles Ltd.
                   9.3. Company Market Position Analysis
                   9.4. List of Other Key Market Participants

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert